Skip to content
Menu

Goldman Sachs Maintains Buy on Xylem, Lowers Price Target to $138

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Goldman Sachs analyst Brian Lee maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $160 to $138.

Goldman Sachs analyst Brian Lee maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $160 to $138.

Read at benzinga.com

← All stock news